Pharmalot... Pharmalittle... The Weekend Nears

And so, yet another working week will soon draw to a close. Not a moment too soon, yes? As always, this is our treasured signal to daydream about weekend plans. Our agenda is rather modest, although we do look forward to spending time not only with our full roster of short people but some of the Pharmalot ancestors. We also hope to catch up on sundry tasks and catch up on some reading. Why not, you know? But what about you? Given the upcoming holiday break, perhaps this marks the beginning of a longer stretch than usual. Presumably, all sorts of activities and possibilities are in store. Spending time with special people or fleeing to distant horizons. You can also enjoy the spoils of life or simply take a bunch of naps. Well, whatever you do, have a grand time and, of course, be safe. See you soon... Ariad Gets FDA OK To Return Cancer Drug To Market (Bloomberg News) AstraZeneca Loses Bid To Thwart Generic Nexium (Reuters) India's Domestic Drug Market Growth Slowed (Bloomberg News) Jazz Pharma To Buy Italy's Gentium For $1B (Pharma Times) Germany Extends Freeze On Drug Prices (BioCentury) Vertex Cystic Fibrosis Drug Misses Trial Goal (Reuters) Sanofi To Tap ACC Register For...Read more
Source: Pharmalot - Category: Pharma Commentators Authors: Source Type: blogs